» Articles » PMID: 34914045

Artificial Intelligence in Vaccine and Drug Design

Overview
Specialty Molecular Biology
Date 2021 Dec 16
PMID 34914045
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Knowledge in the fields of biochemistry, structural biology, immunological principles, microbiology, and genomics has all increased dramatically in recent years. There has also been tremendous growth in the fields of data science, informatics, and artificial intelligence needed to handle this immense data flow. At the intersection of wet lab and data science is the field of bioinformatics, which seeks to apply computational tools to better understanding of the biological sciences. Like so many other areas of biology, bioinformatics has transformed immunology research leading to the discipline of immunoinformatics. Within this field, many new databases and computational tools have been created that increasingly drive immunology research, in many cases drawing upon artificial intelligence and machine learning to predict complex immune system behaviors, for example, prediction of B cell and T cell epitopes. In this book chapter, we provide an overview of computational tools and artificial intelligence being used for protein modeling, drug screening, vaccine design, and highlight how these tools are being used to transform approaches to pandemic countermeasure development, by reference to the current COVID-19 pandemic.

Citing Articles

Bioinformatics Approaches in the Development of Antifungal Therapeutics and Vaccines.

Ahlawat V, Sura K, Singh B, Dangi M, Chhillar A Curr Genomics. 2024; 25(5):323-333.

PMID: 39323620 PMC: 11420568. DOI: 10.2174/0113892029281602240422052210.


Revolutionizing adjuvant development: harnessing AI for next-generation cancer vaccines.

Zhang W, Zheng X, Coghi P, Chen J, Dong B, Fan X Front Immunol. 2024; 15:1438030.

PMID: 39206192 PMC: 11349682. DOI: 10.3389/fimmu.2024.1438030.


Transforming Aquaculture through Vaccination: A Review on Recent Developments and Milestones.

Tammas I, Bitchava K, Gelasakis A Vaccines (Basel). 2024; 12(7).

PMID: 39066370 PMC: 11281524. DOI: 10.3390/vaccines12070732.


mRNA therapeutics: New vaccination and beyond.

Wei H, Zheng L, Wang Z Fundam Res. 2024; 3(5):749-759.

PMID: 38933291 PMC: 10017382. DOI: 10.1016/j.fmre.2023.02.022.


Clinical development of SpikoGen®, an Advax-CpG55.2 adjuvanted recombinant spike protein vaccine.

Petrovsky N Hum Vaccin Immunother. 2024; 20(1):2363016.

PMID: 38839044 PMC: 11155708. DOI: 10.1080/21645515.2024.2363016.


References
1.
Bishop C . Model-based machine learning. Philos Trans A Math Phys Eng Sci. 2013; 371(1984):20120222. PMC: 3538442. DOI: 10.1098/rsta.2012.0222. View

2.
Senior A, Evans R, Jumper J, Kirkpatrick J, Sifre L, Green T . Improved protein structure prediction using potentials from deep learning. Nature. 2020; 577(7792):706-710. DOI: 10.1038/s41586-019-1923-7. View

3.
Yang J, Anishchenko I, Park H, Peng Z, Ovchinnikov S, Baker D . Improved protein structure prediction using predicted interresidue orientations. Proc Natl Acad Sci U S A. 2020; 117(3):1496-1503. PMC: 6983395. DOI: 10.1073/pnas.1914677117. View

4.
Zhang L, Tan J, Han D, Zhu H . From machine learning to deep learning: progress in machine intelligence for rational drug discovery. Drug Discov Today. 2017; 22(11):1680-1685. DOI: 10.1016/j.drudis.2017.08.010. View

5.
Ma J, Sheridan R, Liaw A, Dahl G, Svetnik V . Deep neural nets as a method for quantitative structure-activity relationships. J Chem Inf Model. 2015; 55(2):263-74. DOI: 10.1021/ci500747n. View